Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients

NCT04028713 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT04028713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04028713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Terminated
Start date
February 16, 2021
Completion date
March 22, 2022
Enrollment
19 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris